These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

778 related items for PubMed ID: 28794616

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress.
    Yang JH, Kim SC, Kim KM, Jang CH, Cho SS, Kim SJ, Ku SK, Cho IJ, Ki SH.
    Eur J Pharmacol; 2016 Jul 15; 783():92-102. PubMed ID: 27151496
    [Abstract] [Full Text] [Related]

  • 4. Schisandrin B suppresses liver fibrosis in rats by targeting miR-101-5p through the TGF-β signaling pathway.
    Cuiqiong W, Chao X, Xinling F, Yinyan J.
    Artif Cells Nanomed Biotechnol; 2020 Dec 15; 48(1):473-478. PubMed ID: 31975615
    [Abstract] [Full Text] [Related]

  • 5. The effects of inhibiting the activation of hepatic stellate cells by lignan components from the fruits of Schisandra chinensis and the mechanism of schisanhenol.
    He X, Chen J, Mu Y, Zhang H, Chen G, Liu P, Liu W.
    J Nat Med; 2020 Jun 15; 74(3):513-524. PubMed ID: 32193805
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
    Liu H, Dong F, Li G, Niu M, Zhang C, Han Y, He L, Yin P, Wang B, Sang X, Li R, Wang J, Bai Z, Xiao X.
    J Ethnopharmacol; 2018 Jan 10; 210():232-241. PubMed ID: 28864168
    [Abstract] [Full Text] [Related]

  • 9. Schisantherin A ameliorates liver fibrosis through TGF-β1mediated activation of TAK1/MAPK and NF-κB pathways in vitro and in vivo.
    Wang H, Che J, Cui K, Zhuang W, Li H, Sun J, Chen J, Wang C.
    Phytomedicine; 2021 Jul 15; 88():153609. PubMed ID: 34126414
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Asiatic acid inhibits liver fibrosis by blocking TGF-beta/Smad signaling in vivo and in vitro.
    Tang LX, He RH, Yang G, Tan JJ, Zhou L, Meng XM, Huang XR, Lan HY.
    PLoS One; 2012 Jul 15; 7(2):e31350. PubMed ID: 22363627
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sulforaphane attenuates hepatic fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signaling.
    Oh CJ, Kim JY, Min AK, Park KG, Harris RA, Kim HJ, Lee IK.
    Free Radic Biol Med; 2012 Feb 01; 52(3):671-682. PubMed ID: 22155056
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Chrysin attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway.
    Balta C, Herman H, Boldura OM, Gasca I, Rosu M, Ardelean A, Hermenean A.
    Chem Biol Interact; 2015 Oct 05; 240():94-101. PubMed ID: 26297989
    [Abstract] [Full Text] [Related]

  • 17. Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis via regulation of TGF-β/Smad signaling pathway.
    Zou GL, Zuo S, Lu S, Hu RH, Lu YY, Yang J, Deng KS, Wu YT, Mu M, Zhu JJ, Zeng JZ, Zhang BF, Wu X, Zhao XK, Li HY.
    World J Gastroenterol; 2019 Aug 14; 25(30):4222-4234. PubMed ID: 31435175
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.